Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics, Inc. has filed 353 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.

Recent SEC filings

Form Date Description
8-K 2026-07-29 Unregistered Sales of Equity Securities; Financial Statements and Exhibits
SC 13G 2026-07-28 Beneficial Ownership Report (Passive)
8-K 2026-07-23 Regulation FD Disclosure; Financial Statements and Exhibits
3 2026-07-17 Initial Statement of Beneficial Ownership
SC 13G 2026-07-17 Beneficial Ownership Report (Passive)
8-K 2026-07-14 Other Events; Financial Statements and Exhibits
4 2026-06-30 Statement of Changes in Beneficial Ownership
4 2026-06-30 Statement of Changes in Beneficial Ownership
4 2026-06-30 Statement of Changes in Beneficial Ownership
4 2026-06-30 Statement of Changes in Beneficial Ownership